155 related articles for article (PubMed ID: 25277148)
1. Automated computational framework of blood vessel quantification in chick chorioallantoic membrane angiogenesis.
Shi P; Hong J; Huang Y; Zhang Z; Zhang M; Zhang L
J Biomed Opt; 2014; 19(10):106005. PubMed ID: 25277148
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide.
McKay TL; Gedeon DJ; Vickerman MB; Hylton AG; Ribita D; Olar HH; Kaiser PK; Parsons-Wingerter P
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1184-90. PubMed ID: 18326748
[TBL] [Abstract][Full Text] [Related]
3. The gelatin sponge-chorioallantoic membrane assay.
Ribatti D; Nico B; Vacca A; Presta M
Nat Protoc; 2006; 1(1):85-91. PubMed ID: 17406216
[TBL] [Abstract][Full Text] [Related]
4. IKOSA
Annese T; Tamma R; Ribatti D
Methods Mol Biol; 2023; 2572():129-139. PubMed ID: 36161413
[TBL] [Abstract][Full Text] [Related]
5. Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.
Nowak-Sliwinska P; Ballini JP; Wagnières G; van den Bergh H
Microvasc Res; 2010 Jan; 79(1):21-8. PubMed ID: 19857502
[TBL] [Abstract][Full Text] [Related]
6. [Choline promotes angiogenesis in chick embryo chorioallantoic membrane].
Wang H; Zeng XZ; Cui WY; Duan L
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 May; 29(3):229-31. PubMed ID: 23940955
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study of Solanum nigrum on inhibiting angiogenesis in chick chorioallantoic membrane].
Xu Y; Pan RL; Chang Q; Qin M; Liu Y; Tang JT
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):549-52. PubMed ID: 18536381
[TBL] [Abstract][Full Text] [Related]
8. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
Ayalasomayajula SP; Ashton P; Kompella UB
J Ocul Pharmacol Ther; 2009 Apr; 25(2):97-103. PubMed ID: 19284324
[TBL] [Abstract][Full Text] [Related]
9. Development of collateral vessels: A new paradigm in CAM angiogenesis model.
Gatne DP; Mungekar S; Addepalli V; Mohanraj K; Ghone SA; Rege NN
Microvasc Res; 2016 Jan; 103():11-3. PubMed ID: 26390964
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of vascular colonisation and angio-conduction in porous silicon-substituted hydroxyapatite with various pore shapes in a chick chorioallantoic membrane (CAM) model.
Magnaudeix A; Usseglio J; Lasgorceix M; Lalloue F; Damia C; Brie J; Pascaud-Mathieu P; Champion E
Acta Biomater; 2016 Jul; 38():179-89. PubMed ID: 27131570
[TBL] [Abstract][Full Text] [Related]
11. The chick chorioallantoic membrane as an in vivo angiogenesis model.
Ponce ML; Kleinmann HK
Curr Protoc Cell Biol; 2003 May; Chapter 19():Unit 19.5. PubMed ID: 18228425
[TBL] [Abstract][Full Text] [Related]
12. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents.
As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP
Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736
[TBL] [Abstract][Full Text] [Related]
13. Pluronic F127 as a drug vehicle used in chick embryo chorioallantoic membrane shell-less model.
Shi T; Li Z; Zhang Q; Zheng D; Li Z
Pak J Pharm Sci; 2015 Nov; 28(6):1997-9. PubMed ID: 26639476
[TBL] [Abstract][Full Text] [Related]
14. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
15. The chick embryo chorioallantoic membrane (CAM) assay.
Ribatti D
Reprod Toxicol; 2017 Jun; 70():97-101. PubMed ID: 27832950
[TBL] [Abstract][Full Text] [Related]
16. [Effects of platelet-derived membrane microparticles on angiogenesis in chick chorioallantoic membranes].
Chen BA; Zhong YJ; Huang CY; Li CP; Shi GY; Xiao JY; Tang RC; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Ma Y; Song HH; Fei F; Pei XP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1070-3. PubMed ID: 17956693
[TBL] [Abstract][Full Text] [Related]
17. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
19. Recombinant mouse canstatin inhibits chicken embryo chorioallantoic membrane angiogenesis and endothelial cell proliferation.
Hou WH; Wang TY; Yuan BM; Chai YR; Jia YL; Tian F; Wang JM; Xue LX
Acta Biochim Biophys Sin (Shanghai); 2004 Dec; 36(12):845-50. PubMed ID: 15592653
[TBL] [Abstract][Full Text] [Related]
20. Neridronate inhibits angiogenesis in vitro and in vivo.
Ribatti D; Nico B; Mangieri D; Maruotti N; Longo V; Vacca A; Cantatore FP
Clin Rheumatol; 2007 Jul; 26(7):1094-8. PubMed ID: 17106617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
